-
MDT Single-Arm US Pivotal Trial Goes Better Than Expected, Jefferies Reports
Tuesday, April 5, 2011 - 7:43am | 147Jefferies is reporting that Medtronic's (NYSE: MDT) single-arm (versus a historical control) US pivotal trial for its next-generation RESOLUTE DES “achieved its primary endpoint of TLF non-inferiority in both the clinical and angiographic cohorts.” “Importantly, the trial demonstrated very...
-
Morgan Stanley On Boston Scientific's Promus Element
Tuesday, April 5, 2011 - 7:34am | 96Morgan Stanley has issued a report on Boston Scientific's (NYSE: BSX) presentation of Promus Elements at its ACC analyst meeting. Morgan Stanley writes, "In our view, increased investor confidence in profitability improvement is the most important consequence of the successful PLATINUM trial,...
-
Top 4 Large-Cap Stocks In The Medical Appliances & Equipment Industry With The Lowest PEG Ratio (RBCN, STJ, ZMH, MDT)
Tuesday, April 5, 2011 - 12:40am | 120Below are the top large-cap medical appliances & equipment stocks on the NYSE and the NASDAQ in terms of PEG ratio ResMed Inc (NYSE: RMD) has a PEG ratio of 1.22. RMD's trailing-twelve-month operating margin is 23.14%. St. Jude Medical Inc (NYSE: STJ) has a PEG ratio of 1.28. STJ's trailing-...
-
Earnings Scheduled For April 5 (ANGO, ISCA, KBH, MIND, VRNT, LAYN, ZEP, EDS, MBT, LEDS)
Tuesday, April 5, 2011 - 12:33am | 266AngioDynamics Inc (NASDAQ: ANGO) is expected to report its FQ3 EPS at $0.12 on revenue of $53.89 million. International Speedway Corporation (NASDAQ: ISCA) is estimated to post its FQ1 earnings at $0.48 per share on revenue of $156.60 million. KB Home (NYSE: KBH) is projected to report a Q1 loss...
-
Semiconductors Get Lift 04-04-2011
Monday, April 4, 2011 - 7:35pm | 953Cusick's Corner With the buck easing and the Bonds holding and coming off the worst levels of the day, equities had enough to stay breakeven. Yields need to continue to outpace the bounce in the greenback otherwise the equities could start to get a little nervous....
-
Commodities Up on Strength of Emerging Markets 04-04-2011
Monday, April 4, 2011 - 7:32pm | 894Cusick's Corner The market looked strong on the open but with no headlines or data to pull it along, the market stands at breakeven this Midday. Commodities continue to roll up on the strength of the Emerging Markets -- BRIC countries specifically. Hopefully you did your homework this weekend and...
-
Auditor Announces "Going Concern" For IVAX Diagnostics (IVD)
Monday, April 4, 2011 - 4:08pm | 126IVAX Diagnostics (NYSE: IVD) announced today that its audited consolidated financial statements for the fiscal year ended December 31, 2010, included in its Annual Report on Form 10-K which was filed with the Securities and Exchange Commission on March 30, 2011, contained a report from its...
-
IVAX Diagnostics Announces Going Concern Qualification
Monday, April 4, 2011 - 4:06pm | 127IVAX Diagnostics, Inc. (NYSE: IVD) announced today that its audited consolidated financial statements for the fiscal year ended December 31, 2010, included in its Annual Report on Form 10-K which was filed with the Securities and Exchange Commission on March 30, 2011, contained a report from its...
-
Medtronic: Landmark IMPROVE HF Study Shows Adherence to Outpatient Quality Measures Associated with Improved Survival in Heart Failure Patients
Monday, April 4, 2011 - 4:05pm | 126Results from the largest U.S. outpatient heart failure clinical study, published today in the journal Circulation and funded by Medtronic, Inc. (NYSE: MDT), demonstrate that select guideline-based outpatient heart failure process measures positively impact patient survival and may be useful for...
-
VisualSonics Announces Next Generation In Vivo Imaging Technology to Make Strides in Cancer Risk Reduction, Early Detection, Patient Care, and Survivorship (SONO)
Monday, April 4, 2011 - 3:12pm | 118VisualSonics a wholly-owned subsidiary of SonoSite Inc., (Nasdaq: SONO), is demonstrating the recently announced Vevo® LAZR Photoacoustics Imaging system at the American Association of Cancer Research's annual conference The launch of VisualSonics' Vevo LAZR photoacoustics imaging system enables...
-
Boston Scientific's Promus Element Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Workhorse Trial
Monday, April 4, 2011 - 12:35pm | 83Boston Scientific Corporation (NYSE: BSX) today announced 12-month results from the pivotal PLATINUM Workhorse trial comparing the safety and effectiveness of the PROMUS Element™Everolimus-Eluting Platinum Chromium Coronary Stent System to the PROMUS® Everolimus-Eluting Coronary Stent System....
-
Medtronic Announces Mac Compatibility for CareLink Personal Therapy Management Software for Diabetes
Monday, April 4, 2011 - 12:00pm | 89Medtronic, Inc. (NYSE: MDT) today announced the Food and Drug Administration approval and the market launch of CareLink®Personal 5.4 Therapy Management Software for the Mac OS platform. CareLink Personal is a web-based program that helps people with diabetes assess their glucose control through...
-
Traders Buying Protection on Boston Scientific (BSX)
Monday, April 4, 2011 - 11:59am | 122Shares of Boston Scientific Corporation (NYSE: BSX) are lower on the session by 2.47%, currently trading at $7.12. The stock has been moving largely lower over the past three months and is currently trading below the 50-day moving average. Options traders are buying puts on the name today. A...
-
Medtronic Resolute®Drug-Eluting Stent Delivers Compelling Clinical Outcomes in Major Studies
Monday, April 4, 2011 - 11:48am | 275Results of two major clinical studies presented at ACC.11 – the 60th Annual Scientific Session & Expo of the American College of Cardiology – demonstrate that the Resolute drug-eluting stent from Medtronic, Inc. (NYSE: MDT), provides a positive and persistent treatment effect for a wide variety...
-
Hospira Submits 510(k) Application to FDA for Symbiq Infusion System Modifications
Monday, April 4, 2011 - 10:15am | 58Hospira, Inc. (NYSE: HSP) today announced that the company has submitted a 510(k) application with the U.S. Food and Drug Administration for modifications to the Symbiq infusion system. The submission is one of the first developed to align with the recent FDA draft guidance for 510(k) infusion...